-
Impact of holoprosencephaly, exomphalos, megacystis and increased nuchal translucency on first-trimester screening for chromosomal abnormalities.
Syngelaki A, Guerra L, Ceccacci I, Efeturk T, Nicolaides KH.
Ultrasound Obstet Gynecol 2017;50:45-48. pdf -
Inverted Pyramid of Care.
Sonek JD, Kagan KO, Nicolaides KH.
Clin Lab Med 2016;36:305-17. pdf -
Clinical significance of first-trimester chorionic bumps: a matched case-control study.
Sana Y, Appiah A, Davison A, Nicolaides KH, Johns J, Ross JA.
Ultrasound Obstet Gynecol 2013;42:585-9. -
Quantitative ELISAs for serum soluble LHCGR and hCG-LHCGR complex: potential diagnostics in first trimester pregnancy screening for stillbirth, down's syndrome, preterm delivery and preeclampsia.
Chambers AE, Griffin C, Naif SA, Mills I, Mills WE, Syngelaki A, Nicolaides KH, Banerjee S.
Reprod Biol Endocrinol 2012;10:113. -
Maternal serum alpha-fetoprotein in normal pregnancy at 11-13 weeks' gestation.
Bredaki FE, Wright D, Akolekar R, Cruz G, Nicolaides KH.
Fetal Diagn Ther 2011;30:274-9. -
The 11-13-week scan: diagnosis and outcome of holoprosencephaly, exomphalos and megacystis.
Kagan KO, Staboulidou I, Syngelaki A, Cruz JJ, Nicolaides KH.
Ultrasound Obstet Gynecol 2010;36:10-4. -
The 11-14 week scan.
Nicolaides KH, Heath V, Liao AW.
Baillieres Best Pract Res Clin Obstet Gynaecol 2000;14:581-94. -
Pathophysiology of increased nuchal translucency in chromosomally abnormal fetuses.
von Kaisenberg CS, Brand-Saberi B, Jonat W, Nicolaides KH.
Der Gynäkologe 1999;32:193-199. -
A screening program for trisomy 21 at 10-14 weeks using fetal nuchal translucency, maternal serum free beta-human chorionic gonadotropin and pregnancy-associated plasma protein-A.
Spencer K, Souter V, Tul N, Snijders R, Nicolaides KH.
Ultrasound Obstet Gynecol 1999;13:231-7. -
Cervical length at 23 weeks in twins in predicting spontaneous preterm delivery.
Souka AP, Heath V, Flint S, Sevastopoulou I, Nicolaides KH.
Obstet Gynecol 1999;94:450-4. -
International, collaborative assessment of 146,000 prenatal karyotypes: expected limitations if only chromosome-specific probes and fluorescent in-situ hybridization are used.
Evans MI, Henry GP, Miller WA, Bui TH, Snidjers RJ, Wapner RJ, Miny P, Johnson MP, Peakman D, Johnson A, Nicolaides K, Holzgreve W, Ebrahim SA, Babu R, Jackson L.
Hum Reprod 1999;14:1213-6. -
First trimester umbilical venous Doppler sonography in chromosomally normal and abnormal fetuses.
Brown RN, Di Luzio L, Gomes C, Nicolaides KH.
J Ultrasound Med 1999;18:543-6. -
Investigation of maternal blood enriched for fetal cells: role in screening and diagnosis of fetal trisomies.
Al-Mufti R, Hambley H, Farzaneh F, Nicolaides KH.
Am J Med Genet 1999;2;85:66-75. -
Screening for fetal abnormalities in multiple pregnancies.
Sebire NJ, Nicolaides KH.
Baillieres Clin Obstet Gynaecol 1998;12:19-36.